Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca reports top-line Phase III KRONOS trial results for PT010 triple combination therapy in chronic obstructive pulmonary disease
-
AstraZeneca listed as one of the world’s top-100 most sustainable companies and recognised for its three-fold increase in renewable energy usage
-
Lynparza receives approval in Japan for the treatment of advanced ovarian cancer
-
Fasenra receives approval in Japan
-
Lynparza approved by US FDA in germline BRCA-mutated metastatic breast cancer
-
AstraZeneca receives EU approval of Fasenra for severe eosinophilic asthma
-
US FDA accepts regulatory submission for Tagrisso in 1st-line EGFR-mutated non-small cell lung cancer
-
AstraZeneca to highlight its commitment to blood cancers at the 2017 American Society of Hematology Annual Meeting
-
Tudorza reduces exacerbations and demonstrates cardiovascular safety in COPD patients
-
The European Medicines Agency accepts regulatory submission for Tagrisso in 1st-line EGFR-mutated non-small cell lung cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
